Maynard Um
-
-
-
-
-
-
-
Leerink Partners Downgrades Aurinia Pharmaceuticals (AUPH) to Market Perform
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) call put ratio 62 calls to 1 put with a focus on August and September calls
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Tops Q1 EPS by 5c, provides guidance
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS in Treating Lupus Nephritis
-
-
-
-
-
-
422,315 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

